ATE293990T1 - Mittel und therapieverfahren für auf igf-i ansprechende erkrankungen - Google Patents

Mittel und therapieverfahren für auf igf-i ansprechende erkrankungen

Info

Publication number
ATE293990T1
ATE293990T1 AT98921004T AT98921004T ATE293990T1 AT E293990 T1 ATE293990 T1 AT E293990T1 AT 98921004 T AT98921004 T AT 98921004T AT 98921004 T AT98921004 T AT 98921004T AT E293990 T1 ATE293990 T1 AT E293990T1
Authority
AT
Austria
Prior art keywords
igf
gag
variant
therapy
agents
Prior art date
Application number
AT98921004T
Other languages
English (en)
Inventor
Bruce F Scharschmidt
Alfredo Gorio
Eugenio E Mueller
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE293990T1 publication Critical patent/ATE293990T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98921004T 1997-05-06 1998-05-06 Mittel und therapieverfahren für auf igf-i ansprechende erkrankungen ATE293990T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI001042A IT1291307B1 (it) 1997-05-06 1997-05-06 Composizione farmaceutica atta al trattamento delle patologie neurodegenerative
PCT/US1998/009273 WO1998050062A1 (en) 1997-05-06 1998-05-06 Compositions and methods of therapy for igf-i-responsive conditions

Publications (1)

Publication Number Publication Date
ATE293990T1 true ATE293990T1 (de) 2005-05-15

Family

ID=11377071

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98921004T ATE293990T1 (de) 1997-05-06 1998-05-06 Mittel und therapieverfahren für auf igf-i ansprechende erkrankungen

Country Status (7)

Country Link
EP (1) EP1015019B1 (de)
JP (1) JP2002507193A (de)
AT (1) ATE293990T1 (de)
AU (1) AU7370798A (de)
DE (1) DE69829982T2 (de)
IT (1) IT1291307B1 (de)
WO (1) WO1998050062A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2689694A1 (en) * 1999-07-21 2001-02-01 Omeros Corporation Solutions and methods for inhibition of pain, inflammation and cartilage degradation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0516901A1 (de) * 1991-06-06 1992-12-09 Richard L. Lindstrom Methode und Einrichtung für serumlose medizinische Lösung

Also Published As

Publication number Publication date
WO1998050062A1 (en) 1998-11-12
JP2002507193A (ja) 2002-03-05
ITMI971042A0 (de) 1997-05-06
AU7370798A (en) 1998-11-27
ITMI971042A1 (it) 1998-11-06
EP1015019A1 (de) 2000-07-05
EP1015019B1 (de) 2005-04-27
IT1291307B1 (it) 1999-01-07
DE69829982T2 (de) 2006-02-23
DE69829982D1 (de) 2005-08-18

Similar Documents

Publication Publication Date Title
BR0108173A (pt) Composições farmacêuticas de toxina de botulina
ES2190472T3 (es) Parche transdermico para la administracion de 17-deacetil norgestimato, solo o en combinacion con un estrogeno.
DE69214938D1 (de) Mittel zur topischen verabreichung von arzneiwirkstoffen
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
DE69735581D1 (de) Dosierungsform für eine verzögerte und zunehmende wirkstoffsfreisetzung
DE69940674D1 (de) Orale verabreichung von adenosin analogen
HK1024865A1 (en) Pharmaceutical compositions comprising a mixture of autocross-linked hyaluronic acid and nonautocross-linked hyaluronic acid and their use for the treatment of arthropathies
DE69531098D1 (de) Piperidine und pyrrolidine
ECSP034883A (es) Amidas de acidos antranilicos con cadena lateral de heteroarilsulfonilo, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como preparados farmaceuticos que las contienen
DK0781281T3 (da) Beta-Carbolinderivater som melatonin-agonister, fremgangsmåder til fremstilling deraf og deres anvendelse som lægemiddel
DE69521693D1 (de) Taxanderivate enthaltende arzneizubereitungen
ATE359823T1 (de) Zusammensetzung, welche ein antifolate und ein methylmalonsäuresenkendes mittel enthält
BR0109672A (pt) Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente
DE60019334D1 (de) Antivirale arznei
ES2168457T3 (es) Composiciones farmaceuticas que comprenden una superoxido dismutasa.
ES2173858T3 (es) Analogos de huperzina a.
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
TW261615B (de)
MXPA02010316A (es) Terapia novedosa para los trastornos asociados con la hiperlipidemia.
ES2114073T3 (es) Regeneracion del higado inducida por morfogenes.
BR0008076A (pt) 16-hidroxiestratrienos como estrogênios de efeito seletivo
DE69133077D1 (de) Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung
BR0311866A (pt) Composições de saponinas ou sapogeninas para terapia de câncer
ATE290858T1 (de) N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties